⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GSK News
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
Global Dermatological Therapeutics Market to Reach USD 97 Billion by 2034 | DelveInsight
globenewswire.com
INCY
ACRS
TAK
AZN
PFE
GSK
JNJ
NVS
SNY
BHC
REGN
ABBV
ALGN
BMY
AMGN
ARCT
CANF
Global Semi-Solid Dosage Drugs Market Size, Share and Trends, 2026-2033 | USD 14.16 Billion Opportunity Fueled by Topical Innovation, Aging Populations, and Online Pharmacy Growth
globenewswire.com
PFE
GSK
JNJ
VTRS
TEVA
BHC
SUN
SNY
TGFb Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
XOMA
AZN
MRK
BMY
AMGN
GSK
TLRY
NBIX
Immune Checkpoint Inhibitors Market Size, Share, Trends, and Global Forecast to 2030 | Next-Generation Targets and Combination Therapies Create New Growth Opportunities
globenewswire.com
BMY
GSK
INCY
NVS
JNJ
SNY
EXR
ERS Genomics and KU Leuven Sign CRISPR/Cas9 License Agreement to Expand CRISPR-Enabled Research Services
prnewswire.com
GSK
MRK
TMO
CTVA
DHR
CRL
CSL nombra a Deborah Waterhouse consejera delegada y directora administrativa
prnewswire.com
GSK
Five years of U.S. real-world evidence reinforce the durable effectiveness and long-term persistence of ViiV Healthcare’s Cabenuva
businesswire.com
GSK
JNJ
Non-Alcoholic Steatohepatitis (NASH/MASH) - Drug Pipeline Insight 2026 | 75+ Candidates Across 70+ Companies Drive Licensing and Investment Opportunities
globenewswire.com
NVO
VKTX
GSK
ALGS
Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer
businesswire.com
GSK
Australia mRNA Therapeutics Market Size and Forecast to 2035 by Application and Disease Indication | 19% CAGR Drives USD 1.78 Billion Opportunity Across Influenza and RSV
globenewswire.com
PFE
ARCT
MRNA
BNTX
AZN
GSK
SNY